UM6P Ventures

UM6P Ventures is a venture capital investment firm established in 2019 as the corporate venture capital arm of Mohammed VI Polytechnic University in Ben Guerir, Morocco. The firm focuses on investing in sectors such as agro bioscience, biomedicine, water, energy, artificial intelligence, and cybersecurity across Africa. By targeting these fields, UM6P Ventures aims to support innovation and drive scientific advancement in the region.

Tarek Mghizou

Senior Investment Analyst

4 past transactions

Infiuss

Venture Round in 2022
Infiuss Health, founded in 2018 and based in Apapa, Lagos, specializes in decentralizing clinical trials by offering remote access to various stages of the research process, including participant screening, recruitment, engagement, e-consent, and follow-up. The company operates a two-sided marketplace that connects researchers with eligible participants, leveraging a strong patient community to streamline the recruitment process. By focusing on a direct-to-patient approach, Infiuss Health enhances access to clinical research studies, facilitating greater participation and engagement in medical research.

WafR

Seed Round in 2022
WafR is a reward-based loyalty startup that offers a platform enabling users to earn phone recharges while shopping at retail outlets. The company develops a mass distribution platform aimed at enhancing profit margins for large retailers. Its application allows users to create grocery accounts, deposit funds, and engage in business transactions. This functionality assists clients in addressing their queries, ultimately helping them to improve market share, sales volume, and profitability by influencing consumer choices.

DeepEcho

Pre Seed Round in 2022
DeepEcho is a healthcare technology company that utilizes artificial intelligence to enhance antenatal diagnosis through dynamic ultrasound imagery. By employing deep learning models that simulate the expertise of trained sonographers and radiologists, DeepEcho aims to prevent avoidable fetal mortality and other adverse outcomes in low to non-medicated pregnancies. The company's software facilitates accurate prenatal assessments, addressing issues such as birth defects, preterm birth, and low birth weight. DeepEcho’s technology is particularly beneficial in medical deserts, where access to specialized care is limited, and also serves to optimize time and resources in developed countries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.